Suppr超能文献

老年房颤患者华法林治疗未充分利用——恐惧还是虚假的安全感!

Underutilization of Warfarin Therapy in Elderly Patients with Atrial Fibrillation - Fear or False Sense of Security!

作者信息

Biria Mazda, Batrash Ahmad, Piallarisetti Jayasree, Vacek James, Berenbom Loren, Lakkireddy Dhanunjaya

机构信息

Medical Subspecialty Service, Kansas City Veterans Affairs Medical Center, Kansas City, MO.

Mid-America Cardiology at the University of Kansas Hospital, Kansas City, KS.

出版信息

J Atr Fibrillation. 2008 Sep 16;1(3):119. doi: 10.4022/jafib.119. eCollection 2008 Sep-Nov.

Abstract

Under utilization of warfarin in elderly patients with atrial fibrillation (AF) has been recognized as a significant health care issue. This study examines the rate and reasons for warfarin underutilization in elderly patients with AF at the Kansas City Veterans Affairs Medical Center. Retrospective study reviewing electronic medical records of all patients aged 65 and older with the diagnosis of atrial fibrillation. Patients on warfarin were excluded. Reasons for not using warfarin were extracted by reviewing the electronic medical record. Anticoagulation indications for these patients were determined based on the ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation. Warfarin was not used by 407 patients (25%) with known AF. Average age was 79+6.2 years. 60% of patients had persistent or permanent AF. Prevalence of risk factors for thromboembolism included hypertension (74%), heart failure or ejection fraction of <40% (21%), diabetes (27%) and coronary artery disease (48%). CHADS (2) scores were documented in the charts less than 1% of the times. Only 11 patients had CHADS (2) score of 0 and 70 had a score of 1. A class I or IIa indication for warfarin therapy was present in 298 (73%) of patients. Return to sinus rhythm (37%) was the most common reason for not using warfarin. In 30% of cases the reason not to use warfarin was not addressed. Other reasons not to use warfarin included fear of falls (7%), prior head or GI bleed (14%), patient refusal & noncompliance (12%). History of CVA or TIA was documented in 12% of patients. Underutilization of warfarin in elderly patients with atrial fibrillation remains a common problem despite their high risk for thromboembolic events. A false sense of security about the paroxysmal nature of AF, lack of proper insight about stroke risk (CHADS (2)), and fear of bleeding are the most common reasons for non use of warfarin.

摘要

老年房颤患者华法林使用不足已被视为一个重大的医疗保健问题。本研究调查了堪萨斯城退伍军人事务医疗中心老年房颤患者华法林使用不足的发生率及原因。回顾性研究,查阅了所有65岁及以上诊断为房颤患者的电子病历。正在使用华法林的患者被排除。通过查阅电子病历提取未使用华法林的原因。根据美国心脏病学会/美国心脏协会/欧洲心脏病学会2006年房颤患者管理指南确定这些患者的抗凝指征。407例(25%)已知房颤患者未使用华法林。平均年龄为79±6.2岁。60%的患者为持续性或永久性房颤。血栓栓塞危险因素的患病率包括高血压(74%)、心力衰竭或射血分数<40%(21%)、糖尿病(27%)和冠状动脉疾病(48%)。CHADS(2)评分在病历中的记录次数不到1%。只有11例患者CHADS(2)评分为0,70例评分为1。298例(73%)患者存在华法林治疗的I类或IIa类指征。恢复窦性心律(37%)是未使用华法林的最常见原因。在30%的病例中,未使用华法林的原因未提及。其他未使用华法林的原因包括担心跌倒(7%)、既往头部或胃肠道出血(14%)、患者拒绝及不依从(12%)。12%的患者有卒中或短暂性脑缺血发作史。尽管老年房颤患者发生血栓栓塞事件的风险很高,但华法林使用不足仍是一个常见问题。对房颤阵发性的错误安全感、对卒中风险(CHADS(2))缺乏正确认识以及对出血的恐惧是未使用华法林的最常见原因。

相似文献

本文引用的文献

5
Warfarin maintenance dosages in the very elderly.老年人群华法林的维持剂量
Am J Health Syst Pharm. 2005 May 15;62(10):1062-6. doi: 10.1093/ajhp/62.10.1062.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验